Root Financial Partners
PROK icon

Root Financial Partners’s ProKidney PROK Stock Holding History

Root Financial Partners’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$28 Buy
+17
New +$29 ﹤0.01% 3769

Other funds holding PROK

Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Propel Bio Management
Propel Bio Management Los Angeles, California $189M AUM 71.31% 1-Year Est. Return
Bleichroeder LP
Bleichroeder LP New York $1.02B AUM 33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Brown University
Brown University Providence, Rhode Island $147M AUM 5.01% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

Root Financial Partners's PROK Position: Q3 2026 in Review

Root Financial Partners opened a new position in ProKidney (PROK) in Q3 2026: 17 shares worth $28. The stake represents ﹤0.01% of the portfolio and ranks #3769 among its holdings.

67 funds tracked by Wall St. Rank hold PROK as of Q3 2026.

  • Root Financial Partners held 17 shares of ProKidney worth $28 as of Q3 2026.
  • ProKidney was a new Root Financial Partners position in Q3 2026.
  • ProKidney made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3769 holding.
  • 67 funds tracked by Wall St. Rank held ProKidney as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.